Dr. Geoffrey Oxnard on What Molecular Markers to Test for in Advanced NSCLC, and in Whom?

Medicina, #advanced, #alk, #cancer, #cancergrace, #cell, #dana, #egfr, #geoffrey, #grace, #inhibitor, #institute, #kras, #lung, #molecular, #mutation, #nonsmall, #nsclc, #oncology, #oxnard, #testing